Thomas Kassberg
2017
In 2017, Thomas Kassberg earned a total compensation of $2.3M as Chief Business Officers and Executive Vice President at Ultragenyx Pharmaceutical, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,600 |
|---|---|
| Option Awards | $1,376,678 |
| Salary | $418,443 |
| Stock Awards | $335,243 |
| Other | $32,697 |
| Total | $2,331,661 |
Kassberg received $1.4M in option awards, accounting for 59% of the total pay in 2017.
Kassberg also received $168.6K in non-equity incentive plan, $418.4K in salary, $335.2K in stock awards and $32.7K in other compensation.
Rankings
In 2017, Thomas Kassberg's compensation ranked 4,771st out of 14,666 executives tracked by ExecPay. In other words, Kassberg earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,771 out of 14,666 | 68th |
Division Manufacturing | 1,690 out of 5,768 | 71st |
Major group Chemicals And Allied Products | 495 out of 2,074 | 76th |
Industry group Drugs | 381 out of 1,730 | 78th |
Industry Pharmaceutical Preparations | 302 out of 1,329 | 77th |
Source: SEC filing on April 27, 2018.
Kassberg's colleagues
We found five more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2017.
2017
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2017
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2017
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2017
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President of Translational Sciences
2017
Karah Parschauer
Ultragenyx Pharmaceutical